TCF4/β‐catenin binding in the GLUT3 gene occurs at the end of intron 2, in the same intron, and only ~250 bp after the ZEB1 binding site (Masin et al, 2014), demonstrating a central regulatory role for this intragenic enhancer in cancer cells. Here, ZEB1 is linked to cancer.